4 -isopropylphenyl glucitol compounds as SGLT1 inhibitors

Details for Australian Patent Application No. 2010216634 (hide)

Owner Taisho Pharmaceutical Co., Ltd.

Inventors Kakinuma, Hiroyuki; Kobashi, Yohei; Chonan, Tomomichi; Oi, Takahiro; Shiozawa, Fumiyasu; Iwata, Yuki; Kawabe, Kenichi

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010216634

PCT Pub. Number WO2010/095768

Priority 2009-038776 23.02.09 JP

Filing date 23 February 2010

Wipo publication date 26 August 2010

International Classifications

C07D 309/10 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

A61K 31/351 (2006.01) - not condensed with another ring

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

22 September 2011 PCT application entered the National Phase

  PCT publication WO2010/095768 Priority application(s): WO2010/095768

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010216659-Dispersion of rutile titanium oxide particles, method for producing same and use of same

2010216633-Pyrimidin-4(3H)-one derivatives